IL134378A0 - Eprosartan arginyl charge-neutralization- complex and a process for its production and formulation - Google Patents

Eprosartan arginyl charge-neutralization- complex and a process for its production and formulation

Info

Publication number: IL134378A0
Authority: IL; Israel
Prior art keywords: neutralization; formulation; complex; production; eprosartan
Prior art date: 1997-08-06

Application number

IL13437898A

Other versions

IL134378A (en

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-06

Filing date

1998-08-04

Publication date

2001-04-30

1998-08-04 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-04-30 Publication of IL134378A0 publication Critical patent/IL134378A0/en

2004-02-19 Publication of IL134378A publication Critical patent/IL134378A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

IL13437898A 1997-08-06 1998-08-04 Eprosartan arginyl charge-neutralization-complex, its preparation and pharmaceutical compositions comprising it IL134378A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5499097P	1997-08-06	1997-08-06
PCT/US1998/016245 WO1999007365A1 (en)	1997-08-06	1998-08-04	Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation

Publications (2)

Publication Number	Publication Date
IL134378A0 true IL134378A0 (en)	2001-04-30
IL134378A IL134378A (en)	2004-02-19

Family

ID=21994861

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13437898A IL134378A (en)	1997-08-06	1998-08-04	Eprosartan arginyl charge-neutralization-complex, its preparation and pharmaceutical compositions comprising it

Country Status (27)

Country	Link
EP (1)	EP1027047B1 (en)
JP (1)	JP4463975B2 (en)
KR (1)	KR100508044B1 (en)
CN (1)	CN1276724A (en)
AR (1)	AR015930A1 (en)
AT (1)	ATE341325T1 (en)
AU (1)	AU739295B2 (en)
BR (1)	BR9811926A (en)
CA (1)	CA2299470C (en)
CO (1)	CO4960666A1 (en)
CY (1)	CY1105851T1 (en)
CZ (1)	CZ296274B6 (en)
DE (1)	DE69836095T2 (en)
DK (1)	DK1027047T3 (en)
ES (1)	ES2273433T3 (en)
HK (1)	HK1031688A1 (en)
HU (1)	HUP0201624A3 (en)
IL (1)	IL134378A (en)
NO (1)	NO317771B1 (en)
NZ (1)	NZ502644A (en)
PL (1)	PL198875B1 (en)
PT (1)	PT1027047E (en)
SA (1)	SA98190592B1 (en)
TR (1)	TR200000350T2 (en)
TW (1)	TW570921B (en)
WO (1)	WO1999007365A1 (en)
ZA (1)	ZA987018B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA991922B (en) *	1998-03-11	1999-09-13	Smithkline Beecham Corp	Novel compositions of eprosartan.
WO2000066161A1 (en) *	1999-04-28	2000-11-09	Takeda Chemical Industries, Ltd.	Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
KR20120058618A (en)	2003-01-31	2012-06-07	다이이찌 산쿄 가부시키가이샤	Medicine for prevention of and treatment for arteriosclerosis and hypertension
NO323391B1 (en)	2005-09-28	2007-04-23	Hts Hans Torgersen & Sonn As	children Pose
EP2167047A2 (en) *	2007-06-06	2010-03-31	Dexcel Ltd.	Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
JP5476782B2 (en) *	2009-04-21	2014-04-23	大正製薬株式会社	Method for producing arginine-containing tablets
JP5446716B2 (en) *	2009-10-21	2014-03-19	大正製薬株式会社	Method for producing tablets containing arginine and carnitine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5185351A (en) *	1989-06-14	1993-02-09	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) *	1990-07-31	1994-01-26	Smithkline Beecham Corp	Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
WO1992010189A1 (en) *	1990-12-14	1992-06-25	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
DE69131021T2 (en) *	1990-12-14	1999-08-12	Smithkline Beecham Corp., Philadelphia, Pa. 19101	ANGIOTENSIN II RECEPTOR BLOCKING COMPOSITIONS
US5187159A (en) *	1991-10-07	1993-02-16	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
DE4208052A1 (en) *	1992-03-13	1993-09-16	Bayer Ag	IMIDAZOLYL SUBSTITUTED PHENYL ACIDANCE AMIDE
FR2688781B1 (en) *	1992-03-23	1994-07-01	Sanofi Elf	IMIDAZOLINES N-SUBSTITUTED BY A BIPHENYLMETHYL GROUP, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE4210787A1 (en) *	1992-04-01	1993-10-07	Bayer Ag	Cycloalkyl- and heterocyclyl-substituted imidazolylpropenoic acid derivatives
JPH0841053A (en) *	1994-07-28	1996-02-13	Nkk Corp	Pyrimidine derivative bearing heteroarylalkyl group and angiotensin ii antagonist containing the same
US5645839A (en) *	1995-06-07	1997-07-08	Trustees Of Boston University	Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
KR19990072123A (en) *	1995-12-14	1999-09-27	폴락 돈나 엘.	Antagonists of gonadotropin-releasing hormone and pharmaceutical compositions containing the same

1998
- 1998-08-04 CZ CZ20000406A patent/CZ296274B6/en not_active IP Right Cessation
- 1998-08-04 BR BR9811926-5A patent/BR9811926A/en not_active Application Discontinuation
- 1998-08-04 PT PT98939213T patent/PT1027047E/en unknown
- 1998-08-04 CN CN98809802A patent/CN1276724A/en active Pending
- 1998-08-04 JP JP2000506956A patent/JP4463975B2/en not_active Expired - Fee Related
- 1998-08-04 HU HU0201624A patent/HUP0201624A3/en unknown
- 1998-08-04 PL PL341562A patent/PL198875B1/en not_active IP Right Cessation
- 1998-08-04 AU AU87688/98A patent/AU739295B2/en not_active Ceased
- 1998-08-04 IL IL13437898A patent/IL134378A/en not_active IP Right Cessation
- 1998-08-04 CA CA2299470A patent/CA2299470C/en not_active Expired - Fee Related
- 1998-08-04 WO PCT/US1998/016245 patent/WO1999007365A1/en active IP Right Grant
- 1998-08-04 EP EP98939213A patent/EP1027047B1/en not_active Expired - Lifetime
- 1998-08-04 AT AT98939213T patent/ATE341325T1/en active
- 1998-08-04 DK DK98939213T patent/DK1027047T3/en active
- 1998-08-04 DE DE69836095T patent/DE69836095T2/en not_active Expired - Lifetime
- 1998-08-04 ES ES98939213T patent/ES2273433T3/en not_active Expired - Lifetime
- 1998-08-04 KR KR10-2000-7001173A patent/KR100508044B1/en not_active IP Right Cessation
- 1998-08-04 NZ NZ502644A patent/NZ502644A/en unknown
- 1998-08-04 TR TR2000/00350T patent/TR200000350T2/en unknown
- 1998-08-05 AR ARP980103871A patent/AR015930A1/en active IP Right Grant
- 1998-08-05 ZA ZA987018A patent/ZA987018B/en unknown
- 1998-08-10 CO CO98045455A patent/CO4960666A1/en unknown
- 1998-08-26 TW TW087112928A patent/TW570921B/en not_active IP Right Cessation
- 1998-09-27 SA SA98190592A patent/SA98190592B1/en unknown
2000
- 2000-02-04 NO NO20000577A patent/NO317771B1/en not_active IP Right Cessation
2001
- 2001-01-31 HK HK01100711A patent/HK1031688A1/en not_active IP Right Cessation
2006
- 2006-12-13 CY CY20061101797T patent/CY1105851T1/en unknown

Also Published As

Publication number	Publication date
SA98190592B1 (en)	2006-06-20
NZ502644A (en)	2002-03-01
PL341562A1 (en)	2001-04-23
ATE341325T1 (en)	2006-10-15
CZ2000406A3 (en)	2000-09-13
AU739295B2 (en)	2001-10-11
HUP0201624A2 (en)	2002-12-28
HK1031688A1 (en)	2001-06-22
EP1027047B1 (en)	2006-10-04
CN1276724A (en)	2000-12-13
PT1027047E (en)	2007-01-31
AU8768898A (en)	1999-03-01
AR015930A1 (en)	2001-05-30
CZ296274B6 (en)	2006-02-15
KR20010022582A (en)	2001-03-26
PL198875B1 (en)	2008-07-31
JP2001513498A (en)	2001-09-04
EP1027047A1 (en)	2000-08-16
EP1027047A4 (en)	2002-09-18
CA2299470A1 (en)	1999-02-18
HUP0201624A3 (en)	2003-03-28
TW570921B (en)	2004-01-11
ES2273433T3 (en)	2007-05-01
CO4960666A1 (en)	2000-09-25
CY1105851T1 (en)	2011-02-02
NO317771B1 (en)	2004-12-13
BR9811926A (en)	2000-08-22
JP4463975B2 (en)	2010-05-19
CA2299470C (en)	2010-01-26
ZA987018B (en)	1999-02-08
KR100508044B1 (en)	2005-08-17
WO1999007365A1 (en)	1999-02-18
DK1027047T3 (en)	2007-01-29
NO20000577L (en)	2000-02-29
NO20000577D0 (en)	2000-02-04
TR200000350T2 (en)	2000-12-21
DE69836095D1 (en)	2006-11-16
DE69836095T2 (en)	2007-04-12
IL134378A (en)	2004-02-19

Publication	Publication Date	Title
IL136831A0 (en)	2001-06-14	Process for manufacturing bite-dispersion tablets
HUP0002997A3 (en)	2003-02-28	Process and apparatus for the production of a detergent composition
AU2002300238A1 (en)	2002-12-19	Process for manufacturing bite-dispersion tablets
EG23889A (en)	2007-12-12	Eprosartan dihydrate and a process for its production and formulation
CY2551B1 (en)	2008-07-02	Process for preparing eprosartan
CY2555B1 (en)	2008-07-02	Process for preparing eprosartan
EP0919603A4 (en)	2001-05-30	Process for producing labeled article
IL134378A0 (en)	2001-04-30	Eprosartan arginyl charge-neutralization- complex and a process for its production and formulation
GB9819651D0 (en)	1998-11-04	Matrerial and process for its production
SI1027047T1 (en)	2006-12-31	Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation
GB9709762D0 (en)	1997-07-09	Production process
EP1088584A4 (en)	2004-05-12	Process for producing microcapsules and microcapsules obtained thereby
GB9711802D0 (en)	1997-08-06	Process for confectionery production
AU9436398A (en)	1999-03-22	Caprolactam production process
SI0889880T1 (en)	2003-10-31	Eprosartan dihydrate and a process for its production and formulation
GB9705507D0 (en)	1997-05-07	Production process
ZA984031B (en)	1999-11-15	Process and apparatus for the production of a detergent composition.

Legal Events

Date	Code	Title
2004-07-25	FF	Patent granted
2004-09-27	KB	Patent renewed
2008-12-29	KB	Patent renewed
2013-03-24	MM9K	Patent not in force due to non-payment of renewal fees